in vivo induction of the lymphokine-activated killer phenomenon : interleukin 2-dependent human non-major histocompatibility complex-restricted cytotoxicity generated in vivo during administration of human recombinant interleukin 2 .
C0021756
interleukin
C0218986
human recombinant interleukin 2